About
Adline Chem Lab Limited markets pharmaceutical products in India and internationally. It also offers anti-infectives, gastroentology, haemostatic, padeatric, and bone health pharmaceutical related products. In addition, it provides hepatocare, pain and inflammation, pregnancy and reproductive care, respiratory care, and multi-vitamins in tablet, capsule, liquid orals, and injection forms. Further, the company offers veterinary products and educational supplements. The company was formerly known as Kamron Laboratories Limited and changed its name to Adline Chem Lab Limited in October 2021. Adline Chem Lab Limited was incorporated in 1988 and is based in Ahmedabad, India.
Key Metrics
as of Sep 2026Market Cap7 Cr
P/E—
Div Yield0.00 %
Book Value₹-3.03
52w High₹17.10
52w Low₹7.60
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.04 | 0.08 | 0.03 | 0.05 | 0.03 | 0.06 | 0.10 | 0.07 | 0.10 | 0.07 | 0.00 | 0.03 | 0.08 |
| Operating Profit | -0.04 | -0.08 | -0.03 | -0.05 | -0.03 | -0.06 | -0.10 | -0.07 | -0.10 | -0.07 | 0.00 | -0.03 | -0.08 |
| Other Income | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.03 | 0.03 | 0.00 |
| Profit before tax | 0.03 | -0.11 | -0.07 | -0.08 | -0.06 | 0.16 | -0.13 | -0.10 | -0.13 | -0.04 | -0.03 | -0.06 | -0.08 |
| Tax % | -33.33 | -9.09 | -14.29 | -12.50 | -16.67 | -31.25 | -7.69 | -10.00 | -7.69 | 0.00 | -33.33 | -16.67 | 0.00 |
| Net Profit | 0.04 | -0.09 | -0.06 | -0.07 | -0.05 | 0.21 | -0.12 | -0.09 | -0.13 | -0.04 | -0.02 | -0.05 | -0.08 |
| EPS in Rs | 0.07 | -0.15 | -0.10 | -0.12 | -0.09 | 0.36 | -0.21 | -0.15 | -0.22 | -0.07 | -0.03 | -0.09 | -0.14 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | 6.33 | 6.59 | 5.59 | 8.10 | 17.18 | 16.94 | 15.36 |
| Expenses | 0.15 | 0.30 | 0.18 | 0.80 | 1.04 | 6.56 | 9.91 | 5.01 | 7.23 | 15.97 | 16.50 | 14.42 |
| Operating Profit | -0.15 | -0.30 | -0.18 | -0.80 | -0.30 | -0.23 | -3.32 | 0.58 | 0.87 | 1.21 | 0.44 | 0.94 |
| OPM % | — | — | — | — | -40.54 | -3.63 | -50.38 | 10.38 | 10.74 | 7.04 | 2.60 | 6.12 |
| Other Income | 0.01 | 0.25 | 0.00 | -3.35 | 1.33 | 0.00 | 0.26 | 0.25 | 0.21 | 0.08 | 0.10 | 0.08 |
| Interest | 0.18 | 0.16 | 0.12 | 0.00 | 0.01 | 0.03 | 0.02 | 0.07 | 0.34 | 0.32 | 0.44 | 0.48 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.09 | 0.35 | 1.02 | 0.42 | 0.73 | 0.73 | 0.96 | 0.09 | 0.51 |
| Profit before tax | -0.32 | -0.21 | -0.30 | -4.24 | 0.67 | -1.28 | -3.50 | 0.03 | 0.01 | 0.01 | 0.01 | 0.03 |
| Tax % | -12.50 | -33.33 | -10.00 | 0.00 | -7.46 | 0.00 | 7.43 | 0.00 | 100.00 | 0.00 | 100.00 | 33.33 |
| Net Profit | -0.28 | -0.13 | -0.27 | -4.23 | 0.72 | -1.28 | -3.76 | 0.03 | 0.00 | 0.01 | 0.01 | 0.02 |
| EPS in Rs | -0.48 | -0.22 | -0.46 | -7.23 | 1.23 | -2.19 | -6.43 | 0.05 | 0.00 | 0.02 | 0.02 | 0.03 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 |
| Reserves | -7.62 | -7.34 | -7.22 | -7.42 | -3.20 | -3.92 | -2.64 | 1.18 | 1.18 | 1.19 | 1.21 | 1.21 |
| Borrowings | 1.80 | 1.49 | 1.36 | 1.33 | 1.32 | 2.50 | 2.85 | 5.35 | 11.32 | 9.94 | 9.01 | 9.25 |
| Other Liabilities | 0.04 | 0.08 | 0.06 | 0.31 | 0.91 | 1.20 | 1.52 | 9.46 | 5.01 | 3.97 | 2.34 | 2.32 |
| Total Liabilities | 0.07 | 0.08 | 0.05 | 0.07 | 4.88 | 5.63 | 7.58 | 21.84 | 23.36 | 20.95 | 18.41 | 18.63 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 4.43 | 3.64 | 4.78 | 11.99 | 12.45 | 12.68 | 10.27 | 10.08 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | 0.20 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.07 | 0.08 | 0.05 | 0.07 | 0.45 | 1.99 | 2.80 | 9.85 | 10.91 | 8.27 | 7.94 | 8.35 |
| Total Assets | 0.07 | 0.08 | 0.05 | 0.07 | 4.88 | 5.63 | 7.58 | 21.84 | 23.36 | 20.95 | 18.41 | 18.63 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.16 | -0.23 | -0.17 | 0.01 | 0.21 | -0.29 | -11.34 | -0.95 | 0.89 | 2.46 | 0.83 | 0.39 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 11.24 | -0.28 | -0.37 | -3.18 | -0.21 | -2.44 |
| Cash from Financing Activity | 0.16 | 0.25 | 0.15 | 0.00 | -0.01 | -0.03 | -0.02 | -0.29 | 1.04 | 0.63 | -0.78 | 2.18 |
| Net Cash Flow | 0.00 | 0.02 | -0.02 | 0.01 | 0.20 | -0.21 | -0.12 | -1.51 | 1.56 | -0.09 | -0.15 | 0.12 |
| Free Cash Flow | -0.16 | -0.23 | -0.17 | 0.01 | 0.21 | -0.17 | -0.10 | -1.23 | 0.36 | -0.73 | 0.62 | -2.06 |
| CFO/OP % | 107.00 | 110.00 | 94.00 | -1.00 | -70.00 | 126.00 | 342.00 | -164.00 | 102.00 | 203.00 | 189.00 | 41.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | — | 34.53 | 91.11 | 79.20 | 135.81 | 102.74 | 56.30 | 53.87 | 57.74 |
| Inventory Days | — | 0.00 | 197.71 | 46.98 | 81.53 | 832.82 | 181.31 | 55.54 | 46.15 | 77.67 |
| Days Payable | — | — | 342.19 | 28.91 | 41.89 | 436.97 | 63.34 | 49.24 | 41.39 | 43.12 |
| Cash Conversion Cycle | — | — | -109.95 | 109.18 | 118.84 | 531.66 | 220.71 | 62.60 | 58.62 | 92.30 |
| Working Capital Days | — | — | -764.53 | -66.89 | -72.00 | -317.99 | -139.69 | -29.53 | -6.46 | 24.71 |
| ROCE % | -933.33 | 5.90 | -10.95 | -23.83 | -40.35 | 0.59 | 1.98 | 2.00 | 2.84 | 3.39 |
Corporate Actions
No corporate actions recorded.